Clinical equivalence and non-inferiority within health technology assessment

23 February 2026 - Non-inferiority and clinical equivalence clinical trials can be used to determine whether a health technology is no ...

Read more →

The IQWiG methods: new version is effective immediately

19 December 2025 - With the General Methods 8.0, the new IQWiG methodology for determining minimum staffing levels for service ...

Read more →

Health inequalities - an update to NICE’s methods for health technology evaluation

14 May 2025 - Our new modular update focuses on how we consider health inequalities when evaluating technologies for use in ...

Read more →

Canada’s Drug Agency publishes new guidance for rare disease registries in Canada

28 February 2025 - On Rare Disease Day — a global event dedicated to raising awareness for the millions of ...

Read more →

International collaboration provides new guidance on the use of surrogate outcomes in cost effectiveness analysis

17 January 2025 - Recommendations will help organisations that evaluate new drugs establish whether their use will result in longer-term benefits ...

Read more →

International collaboration provides new guidance on the use of surrogate endpoints in cost effectiveness analysis

9 January 2025 - Recommendations will help organisations that appraise new drugs establish whether their use will result in longer-term ...

Read more →

Canada’s Drug Agency launches consultation on methods guide

28 November 2024 - Canada’s Drug Agency is launching a consultation on its first ever methods guide.  ...

Read more →

New model validation tool to support economic evaluations of health technologies

1 April 2024 - CADTH has developed a comprehensive and accessible tool to support the validation of economic models used in ...

Read more →

NICE launches first modular update to its methods and processes

31 October 2023 - NICE’s methods and processes now include a proportionate approach to technology appraisals, and a new way of ...

Read more →

The evolving nature of health technology assessment: a critical appraisal of NICE’s new methods manual

6 October 2023 - NICE recently completed a review of its methods for health technology assessment, involving a 2 stage ...

Read more →

How IQWiG assesses – version 7.0 of the method paper comes into force

19 September 2023 - Fundamental revision of the cost benefit assessment and addition of the concept of application-accompanying data collection. ...

Read more →

NICE launches public consultation on updates to health technology evaluations manual

27 June 2023 - A public consultation on updates to NICE’s health technology evaluations manual is now open. ...

Read more →

Guidance for reporting real world evidence

31 May 2023 - CADTH has partnered with Health Canada, the Institut national d’excellence en santé et en services sociaux (INESSS), ...

Read more →

Draft methods (version 7.0): IQWiG is extending the comment period

26 January 2023 - The new deadline is 28 February 2023. ...

Read more →

HAS updates its recommendations for the proper use of osteoporosis drugs

24 January 2023 - Osteoporosis is a disease whose first cause is ageing and which is characterised by the reduction ...

Read more →